Tumour necrosis factor (TNF) receptor family in GtoPdb v.2021.3

Authors

DOI:

https://doi.org/10.2218/gtopdb/F334/2021.3

Abstract

Dysregulated TNFR signalling is associated with many inflammatory disorders, including some forms of arthritis and inflammatory bowel disease, and targeting TNF has been an effective therapeutic strategy in these diseases and for cancer immunotherapy [5, 6, 49].

Published

02-Sep-2021

Issue

Section

Summaries

How to Cite

“Tumour necrosis factor (TNF) receptor family in GtoPdb v.2021.3” (2021) IUPHAR/BPS Guide to Pharmacology CITE, 2021(3). doi:10.2218/gtopdb/F334/2021.3.